These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 24140401)

  • 41. Polysubstance use patterns and novel synthetics: A cluster analysis from three U.S. cities.
    Elliott L; Haddock CK; Campos S; Benoit E
    PLoS One; 2019; 14(12):e0225273. PubMed ID: 31794586
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current European data collection on emergency department presentations with acute recreational drug toxicity: gaps and national variations.
    Heyerdahl F; Hovda KE; Giraudon I; Yates C; Dines AM; Sedefov R; Wood DM; Dargan PI
    Clin Toxicol (Phila); 2014 Dec; 52(10):1005-12. PubMed ID: 25361166
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010.
    Hoyte CO; Jacob J; Monte AA; Al-Jumaan M; Bronstein AC; Heard KJ
    Ann Emerg Med; 2012 Oct; 60(4):435-8. PubMed ID: 22575211
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Emerging drugs in Europe.
    Papaseit E; Farré M; Schifano F; Torrens M
    Curr Opin Psychiatry; 2014 Jul; 27(4):243-50. PubMed ID: 24840157
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Designer drugs. Patients may be using synthetic cannabinoids more than you think.
    Lisi DM
    JEMS; 2014 Sep; 39(9):56-9. PubMed ID: 25322519
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 2005 Annual Report of the American Association of Poison Control Centers' national poisoning and exposure database.
    Lai MW; Klein-Schwartz W; Rodgers GC; Abrams JY; Haber DA; Bronstein AC; Wruk KM
    Clin Toxicol (Phila); 2006; 44(6-7):803-932. PubMed ID: 17015284
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Limited use of novel psychoactive substances in South London nightclubs.
    Wood DM; Hunter L; Measham F; Dargan PI
    QJM; 2012 Oct; 105(10):959-64. PubMed ID: 22718853
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A qualitative descriptive analysis of effects of psychedelic phenethylamines and tryptamines.
    Palamar JJ; Acosta P
    Hum Psychopharmacol; 2020 Jan; 35(1):e2719. PubMed ID: 31909513
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Epidemiology of hallucinogenic drug use in the Netherlands].
    van Laar MW; van Miltenburg CJA
    Tijdschr Psychiatr; 2020; 62(8):684-692. PubMed ID: 32816297
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New Drugs of Abuse and Withdrawal Syndromes.
    Andrabi S; Greene S; Moukaddam N; Li B
    Emerg Med Clin North Am; 2015 Nov; 33(4):779-95. PubMed ID: 26493523
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel psychoactive substances: the pharmacology of stimulants and hallucinogens.
    Schifano F; Papanti GD; Orsolini L; Corkery JM
    Expert Rev Clin Pharmacol; 2016 Jul; 9(7):943-54. PubMed ID: 26985969
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Changing Drug Culture: Emerging Drugs of Abuse and Legal Highs.
    Albertson TE; Chenoweth JA; Colby DK; Sutter ME
    FP Essent; 2016 Feb; 441():18-24. PubMed ID: 26881769
    [TBL] [Abstract][Full Text] [Related]  

  • 53. NPS: Medical Consequences Associated with Their Intake.
    Schifano F; Orsolini L; Papanti D; Corkery J
    Curr Top Behav Neurosci; 2017; 32():351-380. PubMed ID: 27272067
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Designer drugs 2015: assessment and management.
    Weaver MF; Hopper JA; Gunderson EW
    Addict Sci Clin Pract; 2015 Mar; 10(1):8. PubMed ID: 25928069
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
    Gillet C; Polard E; Mauduit N; Allain H
    Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New psychoactive substances as adulterants of controlled drugs. A worrying phenomenon?
    Giné CV; Espinosa IF; Vilamala MV
    Drug Test Anal; 2014; 6(7-8):819-24. PubMed ID: 24470121
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Toxicology of New Psychoactive Substances: Synthetic Cathinones and Phenylethylamines.
    Tyrkkö E; Andersson M; Kronstrand R
    Ther Drug Monit; 2016 Apr; 38(2):190-216. PubMed ID: 26587869
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection and characterization of emerging psychoactive substances by ion mobility spectrometry.
    Armenta S; Garrigues S; de la Guardia M; Brassier J; Alcalà M; Blanco M; Perez-Alfonso C; Galipienso N
    Drug Test Anal; 2015 Apr; 7(4):280-9. PubMed ID: 24935207
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Psychonauts' psychedelics: A systematic, multilingual, web-crawling exercise.
    Catalani V; Corkery JM; Guirguis A; Napoletano F; Arillotta D; Zangani C; Vento A; Schifano F
    Eur Neuropsychopharmacol; 2021 Aug; 49():69-92. PubMed ID: 33857740
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nutmeg intoxication in Texas, 1998-2004.
    Forrester MB
    Hum Exp Toxicol; 2005 Nov; 24(11):563-6. PubMed ID: 16323572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.